These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9179631)

  • 41. Anger attacks in bipolar depression: predictors and response to citalopram added to mood stabilizers.
    Mammen OK; Pilkonis PA; Chengappa KN; Kupfer DJ
    J Clin Psychiatry; 2004 May; 65(5):627-33. PubMed ID: 15163248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validity of the depressive dimension extracted from principal component analysis of the PANSS in drug-free patients with schizophrenia.
    El Yazaji M; Battas O; Agoub M; Moussaoui D; Gutknecht C; Dalery J; d'Amato T; Saoud M
    Schizophr Res; 2002 Jul; 56(1-2):121-7. PubMed ID: 12084426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for a combined genetic effect of the 5-HT(1A) receptor and serotonin transporter genes in the clinical outcome of major depressive patients treated with citalopram.
    Arias B; Catalán R; Gastó C; Gutiérrez B; Fañanás L
    J Psychopharmacol; 2005 Mar; 19(2):166-72. PubMed ID: 15728438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia.
    Friedman JI; Ocampo R; Elbaz Z; Parrella M; White L; Bowler S; Davis KL; Harvey PD
    J Clin Psychopharmacol; 2005 Jun; 25(3):237-42. PubMed ID: 15876902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and Safety of Citalopram in Treating Post-Stroke Depression: A Meta-Analysis.
    Tan S; Huang X; Ding L; Hong H
    Eur Neurol; 2015; 74(3-4):188-201. PubMed ID: 26559658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response.
    Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E
    Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Escitalopram augmentation improves negative symptoms of treatment resistant schizophrenia patients - A randomized controlled trial.
    Ding N; Li Z; Liu Z
    Neurosci Lett; 2018 Aug; 681():68-72. PubMed ID: 29852208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.
    Mao PX; Tang YL; Jiang F; Shu L; Gu X; Li M; Qian M; Ma C; Mitchell PB; Cai ZJ
    Depress Anxiety; 2008; 25(1):46-54. PubMed ID: 17149753
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Care of depressed patients with anxiety symptoms.
    Nutt DJ
    J Clin Psychiatry; 1999; 60 Suppl 17():23-7; discussion 46-8. PubMed ID: 10446738
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Conclusions inconsistent with results with citalopram.
    Kruszewski SP
    Am J Psychiatry; 2005 Nov; 162(11):2195-6; author reply 2196-7. PubMed ID: 16263873
    [No Abstract]   [Full Text] [Related]  

  • 51. Selective serotonin reuptake inhibitor (SSRI) add-on therapy for the negative symptoms of schizophrenia: a meta-analysis.
    Sepehry AA; Potvin S; Elie R; Stip E
    J Clin Psychiatry; 2007 Apr; 68(4):604-10. PubMed ID: 17474817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Negative symptoms of schizophrenia are improved by paroxetine added to neuroleptics: a pilot study.
    Jockers-Scherübl M; Godemann F; Pietzcker A
    J Clin Psychiatry; 2001 Jul; 62(7):573. PubMed ID: 11488373
    [No Abstract]   [Full Text] [Related]  

  • 54. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.
    Feighner JP; Overø K
    J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Faster onset of antidepressant effects of citalopram compared with sertraline in drug-naïve first-episode major depressive disorder in a Chinese population: a 6-week double-blind, randomized comparative study.
    Hsu JW; Su TP; Huang CY; Chen YS; Chou YH
    J Clin Psychopharmacol; 2011 Oct; 31(5):577-81. PubMed ID: 21869697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
    Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
    J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.
    Lavretsky H; Siddarth P; Kumar A; Reynolds CF
    Int J Geriatr Psychiatry; 2008 Jan; 23(1):55-9. PubMed ID: 17621383
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Citalopram causes no significant alterations in plasma neuroleptic levels in schizophrenic patients.
    Syvälahti EK; Taiminen T; Saarijärvi S; Lehto H; Niemi H; Ahola V; Dahl ML; Salokangas RK
    J Int Med Res; 1997; 25(1):24-32. PubMed ID: 9027670
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache.
    Bendtsen L; Jensen R; Olesen J
    J Neurol Neurosurg Psychiatry; 1996 Sep; 61(3):285-90. PubMed ID: 8795600
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Selective serotonin reuptake inhibitors in treatment of compulsive symptoms within the scope of schizophrenia].
    Scholl HP; Kasper S; Danos P; Höflich G; Möller HJ
    Nervenarzt; 1994 Jul; 65(7):478-81. PubMed ID: 7800092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.